Skip to content
Dose Brief
Menu
No. 476 here · Grade C

Framework review

Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection.

Visit Framework Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from Framework's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://yourframework.com/tirz on 2026-08-01 and this row reflects what that page says. That page publishes no monthly medication price, so there is no line for us to track until it does. There is no earlier reading of ours to compare it against yet.

The scorecard

Framework scored on our six Brief Score factors. See the methodology.

Price Stability40/100
Supply Reliability65/100
Transparency47/100
Access Breadth30/100
Clinical Oversight72/100
Track Record63/100

What we like

  • Named 503B pharmacy partner (The Pharmacy Hub) disclosed — the FDA-registered outsourcing-facility pathway, distinct from 503A
  • Publishes the FDA compounded-medication disclaimer
  • $25/week pricing (~$100/mo) is among the most aggressive in the directory
  • $0 membership fees
  • Phone support published, toll-free (888) 412-0666

The caveats

  • No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
  • The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
  • A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
  • Different landing pages advertise different per-week rates, $25 on one and $19 on another
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

The brief

Best for: Readers who want aggressive $25/week pricing with a named 503B pharmacy partner. Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection.

Ranked #476 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Framework.

Closest here

The providers scoring nearest Framework — the realistic shortlist if you're weighing it.

Weighing Framework against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Framework, and every provider that outranks it is listed on the Framework alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Framework's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Framework's site. Not medical advice; see our disclosure.

← Back to all rankings